Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Market Cap	2.68B +9.5%
Revenue (ttm)	739.63M +6.7%
Net Income	-312.73M
EPS	-1.42
Shares Out	220.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,839,319
Average Volume	2,305,005
Open	12.61
Previous Close	12.16
Day's Range	12.50 - 13.37
52-Week Range	9.60 - 14.32
Beta	0.01
RSI	73.35
Earnings Date	May 15, 2026

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, rapid antigen test kits, and automated nucleic acid (NA) extraction instruments in Turkey. It offers microbiology, genetic disorder, multiplex panel, drug resistance sequencing, food testing kits, as well as sample collection and transport; and full automation, manual magnetic bead NA extraction, and automated NA extraction instrument kits. The compan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 249
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ANGEN

Financial Performance

In 2025, IST:ANGEN's revenue was 739.63 million, an increase of 6.65% compared to the previous year's 693.51 million. Losses were -312.73 million, 9.16% more than in 2024.